Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery

Sponsor
Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT03621579
Collaborator
(none)
60
2
1
13
30
2.3

Study Details

Study Description

Brief Summary

Congenital cataract is the main cause of form deprivation amblyopia in children. Current studies confirm that form deprivation amblyopia affects the retinal nerve fiber layer. However, there are different opinions about the effect of amblyopia on the optic nerve fiber thickness around the optic disc at home and abroad. Investigators have performed "cataract extraction with IOL implantation" on children with bilateral and unilateral congenital cataract. Investigators used OCT biometry to measure children's the retinal nerve fiber layer (RNFLT) and macular thickness (CMT) before and after surgery. Investigators dynamically observed changes in RNFL and CMT to explore the retinal mechanism of form deprivation amblyopia and help guide the clinical correct understanding of postoperative follow-up time.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cataract surgery
N/A

Detailed Description

This prospective study reviewed children with CC who were undergoing cataract extraction with IOL implantation at the Eye Hospital of Wenzhou Medical University, Hangzhou, China. bilateral and unilateral CC children were placed in Study group, while age-matched normal children were included as controls. Children who were uncooperative to complete the preoperative and postoperative examinations were excluded.

All eyes were divided into 4 groups. Group 1: form deprivation amblyopia of unilateral CC, Group 2: unaffected eyes of unilateral CC, Group 3: form deprivation amblyopia of bilateral CC, Group 4: normal eyes of normal children. The preoperative and postoperative data including sex, age at surgery, 7 position of RNFLT and CMT were collected.

All surgeries were performed by the same surgeon (Y.E.Z.) under general anesthesia. Investigators used OCT biometry to measure participants' the retinal nerve fiber layer (RNFLT) and macular thickness (CMT) before surgery and 1 week, 1 month, 3 months, and 6 months and 1 year after surgery, and compared with age-matched normal children.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Mar 1, 2018
Actual Study Completion Date :
Apr 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: the RNFLT and CMT

the retinal nerve fiber layer (RNFLT) and macular thickness (CMT)

Procedure: cataract surgery
To measure the RNFLT and CMT in congenital cataracts before and after the cataract extraction with IOL implantation surgery

Outcome Measures

Primary Outcome Measures

  1. RNFLT [1 year]

    the retinal nerve fiber layer thickness (RNFLT)measured by OCT biometry (Units :um)

  2. CMT [1 year]

    the macular thickness (CMT) measured by OCT biometry (Units :um)

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • congenital cataract
Exclusion Criteria:
  • incooperative to complete the preoperative and postoperative examinations

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Hospital of Wenzhou Medical College Wenzhou Zhejiang China 325027
2 Ophthalmology and Optometry Hospital Wenzhou Zhejiang China 325027

Sponsors and Collaborators

  • Wenzhou Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yune Zhao, director, Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT03621579
Other Study ID Numbers:
  • RNFL-HZ
First Posted:
Aug 8, 2018
Last Update Posted:
Aug 8, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yune Zhao, director, Wenzhou Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2018